X

Vous n'êtes pas connecté

Maroc Maroc - WN.COM - Health - 19/Sep 07:32

Genflow Strengthens IP Portfolio

Genflow Strengthens Global IP Portfolio with China Patent Examination Filing for SIRT6 Variants in NASH LONDON, UK / ACCESS Newswire / September 19, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, today announces that it has filed a formal request for the examination of its patent application entitled SIRT6 Variants for NASH in China. The application covers proprietary variants of the SIRT6 gene designed to address Non-Alcoholic Steatohepatitis (NASH), a severe progressive liver disease with limited treatment options. By pursuing examination in China, Genflow is reinforcing its global intellectual...

Articles similaires

Sorry! Image not available at this time

Genflow Biosciences PLC Announces Half-Year Report

wn.com - 30/Sep 08:40

LONDON, UNITED KINGDOM / ACCESS Newswire / September 30, 2025 / Genflow (LSE:GENF)(OTCQB:GENFF) is pleased to announce its half year results for the...

Fatty liver cure: 9 effective home remedies to support fatty liver recovery naturally

times of india - 07/Oct 17:30

Fatty liver disease, simply put, Steatosis and NASH (Non-Alcoholic Steatohepatitis), is one of the leading global health issues, commonly associated...

Sorry! Image not available at this time

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

wn.com - 02/Oct 09:30

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio Commercial Focus Remains on...

Sorry! Image not available at this time

InfoSec Global, a Keyfactor Company, Secures Second U.S. Patent for Cryptographic Agility

financialpost.com - 02/Oct 13:03

New patent enables cryptographic engine replacement, simplifying transitions to crypto-agile, post-quantum-ready security models TORONTO &...

Sorry! Image not available at this time

Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent

financialpost.com - 12:06

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the District Court for the...

Sorry! Image not available at this time

Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent

mangaloremirror.com - 06:15

Business Wire India Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the...

Sorry! Image not available at this time

AIIMS-trained liver specialist shares 3 drinks for patients with fatty liver disease: 'Beetroot juice is ...

wn.com - 05/Oct 07:20

An increased build-up of fat in the liver is known as fatty liver disease. There are two types: one is caused by heavy drinking (alcoholic fatty liver...

Sorry! Image not available at this time

Lenzing AG Refines Strategy And Strengthens Competitiveness For A Challenging Environment

textileworld.com - 29/Sep 19:23

LENZING, Austria — September 29, 2025 — Lenzing AG, a provider of regenerated cellulosic fibers, refined its strategy to strengthen its global...

Sorry! Image not available at this time

Hepatologist says 'night shifts lead to fatty liver', warns against 'certain occupations'

wn.com - 07/Oct 10:32

Night shifts negatively affect health by disrupting natural sleep rhythms. They can lead to mental health issues. But did you know night shifts can...

Sorry! Image not available at this time

Hepatologist says 'night shifts lead to fatty liver', warns against 'certain occupations'

wn.com - 07/Oct 10:32

Night shifts negatively affect health by disrupting natural sleep rhythms. They can lead to mental health issues. But did you know night shifts can...